期刊文献+

SYNERGISTIC EFFICACY OF ADENOVIRUS-MEDIATED BCL-XS GENE TRANSFER AND TOPOTECAN IN OVARIAN CANCER CELL

SYNERGISTIC EFFICACY OF ADENOVIRUS-MEDIATED BCL-XS GENE TRANSFER AND TOPOTECAN IN OVARIAN CANCER CELL
下载PDF
导出
摘要 Objective: To observe the synergistic efficacy between Adenovirus-mediated bcl-Xs(Adv-bcl-Xs) gene transfer and chemotherapy on ovarian cancer cell growth. Methods: NuTu-19 cells were infected by different titers of Adv-bcl-Xs and treated with topotecan in the meantime. Cell proliferation was measured 3 days later by MTT. Graphical representations and statistical analyses for their interaction in tumor cells were done. Results: The statistical result and Graphical representations of the statistical modeling showed synergy effect on cell growth inhibition (P<0.01). Conclusion: There were synergistic efficacies between Adv-bcl-Xs gene therapy and Topotecan in ovarian cancer cell growth. Objective: To observe the synergistic efficacy between Adenovirus-mediated bcl-Xs(Adv-bcl-Xs) gene transfer and chemotherapy on ovarian cancer cell growth. Methods: NuTu-19 cells were infected by different titers of Adv-bcl-Xs and treated with topotecan in the meantime. Cell proliferation was measured 3 days later by MTT. Graphical representations and statistical analyses for their interaction in tumor cells were done. Results: The statistical result and Graphical representations of the statistical modeling showed synergy effect on cell growth inhibition (P<0.01). Conclusion: There were synergistic efficacies between Adv-bcl-Xs gene therapy and Topotecan in ovarian cancer cell growth.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2001年第4期254-257,共4页 中国癌症研究(英文版)
基金 This work was supported by a grant from the Science Foundation of National Committee of Education of China (No. 96361017).
关键词 BCL-XS TOPOTECAN Ovarian Cancer bcl-Xs Topotecan Ovarian Cancer
  • 相关文献

参考文献11

  • 1Jeffrey S. Han,Gabriel Nú?ez,Max S. Wicha,Michael F. Clarke.Targeting cancer cell death with a bcl-xS adenovirus[J].Springer Seminars in Immunopathology.1998(3)
  • 2Chiou SK,Rao L,White E.Bcl-2 blocks P 53-dependentapoptosis[].Molecular and Cellular Biology.1994
  • 3Lowe S W,Ruley H E,Jacks T et al.P53-dependent apoptosis modulates the cytotoxicity of anticancer agents[].Cell.1993
  • 4KamesakiS,KamesakiH,JorgensonTJ,et al.bcl-2 protein inhibits etoposide-induced apoptosis through its effects on event subsequent to topoisomeraseII-inducedDNA strand breaks and their repair[].Cancer Research.1993
  • 5DoleM,NunezG,MerchantAKetal.Bcl-2inhibitschemotherapy-inducedapoptosisinneuroblastoma[].Cancer Research.1994
  • 6Xu Z,Friess H,Solioz M,Aebi S,Korc M,Kleeff J,Buchler MW.Bcl-x (L)antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine[].International Journal of Cancer.2001
  • 7LeechSH,OlieRA,GautschiO,et al.Induction of apoptosis in lung-cancer cells following bcl-xL antisense treatment[].International Journal of Cancer.2000
  • 8Boise L H,Gonzalez-Garcia M,Postema C E,et al.Bcl -x, a bcl 2-related gene that functions as a dominant regulator of apoptotic cell death[].Cell.1993
  • 9DoleMG,ClarkeMF,HolmanP,et al.Bcl-xS enhances adenoviral vector-induced apoptosis in neuroblastoma cells[].CancerRess.1996
  • 10Dole MG,Jasty R,Cooper MJ,et al.bcl-xl is expressed inneuroblastoma cells and modulates chemotherapy-inducedapoptosis[].Cancer Research.1995

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部